Movement Alert｜PHARMARON Falls 3.22% in Regular Trading, CXO Sector Pullback Compounded by Controlling Shareholder Reduction Plan

Market Focus08-14

On August 14, PHARMARON fell 3.22% in regular trading, trading at 29.56 HKD/share, with turnover of approximately 82.26 million HKD.

On the news front, the CXO sector came under broad selling pressure following a sustained prior rally. Within the sector, WuXi AppTec declined 3.30%, GenScript Biotech fell 3.31%, and Insilico dropped 3.84%, indicating a sector-wide correction. At the company level, the controlling shareholder and concert parties had previously announced plans to reduce their combined holdings by up to 2.33%. Additionally, Norges Bank sold 2.8013 million shares on August 7 at approximately 27.23 HKD per share, totaling around 76.28 million HKD, reducing its stake to 4.49%. The confluence of institutional and major shareholder selling pressure weighed on short-term market sentiment, despite the company's upcoming board meeting on August 20 to review interim results, with previously guided first-half revenue growth of 16%-19% year-over-year and new order growth exceeding 30%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184172705?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184172705","market":"us","top_or_hot":-1,"title":"Movement Alert｜PHARMARON Falls 3.22% in Regular Trading, CXO Sector Pullback Compounded by Controlling Shareholder Reduction Plan","media":"Market Focus","content":"<p><p>On August 14, PHARMARON fell 3.22% in regular trading, trading at 29.56 HKD/share, with turnover of approximately 82.26 million HKD.</p><p>On the news front, the CXO sector came under broad selling pressure following a sustained prior rally. Within the sector, WuXi AppTec declined 3.30%, GenScript Biotech fell 3.31%, and Insilico dropped 3.84%, indicating a sector-wide correction. At the company level, the controlling shareholder and concert parties had previously announced plans to reduce their combined holdings by up to 2.33%. Additionally, Norges Bank sold 2.8013 million shares on August 7 at approximately 27.23 HKD per share, totaling around 76.28 million HKD, reducing its stake to 4.49%. The confluence of institutional and major shareholder selling pressure weighed on short-term market sentiment, despite the company's upcoming board meeting on August 20 to review interim results, with previously guided first-half revenue growth of 16%-19% year-over-year and new order growth exceeding 30%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜PHARMARON Falls 3.22% in Regular Trading, CXO Sector Pullback Compounded by Controlling Shareholder Reduction Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜PHARMARON Falls 3.22% in Regular Trading, CXO Sector Pullback Compounded by Controlling Shareholder Reduction Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-14 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 14, PHARMARON fell 3.22% in regular trading, trading at 29.56 HKD/share, with turnover of approximately 82.26 million HKD.</p><p>On the news front, the CXO sector came under broad selling pressure following a sustained prior rally. Within the sector, WuXi AppTec declined 3.30%, GenScript Biotech fell 3.31%, and Insilico dropped 3.84%, indicating a sector-wide correction. At the company level, the controlling shareholder and concert parties had previously announced plans to reduce their combined holdings by up to 2.33%. Additionally, Norges Bank sold 2.8013 million shares on August 7 at approximately 27.23 HKD per share, totaling around 76.28 million HKD, reducing its stake to 4.49%. The confluence of institutional and major shareholder selling pressure weighed on short-term market sentiment, despite the company's upcoming board meeting on August 20 to review interim results, with previously guided first-half revenue growth of 16%-19% year-over-year and new order growth exceeding 30%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1184172705","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184172705","pubTimestamp":1786676948,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 14, PHARMARON fell 3.22% in regular trading, trading at 29.56 HKD/share, with turnover of approximately 82.26 million HKD.On the news front, the CXO sector came under broad selling pressure...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"走势提醒|康龙化成常规交易下跌3.22%，CXO板块因控股股东减持计划而加剧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"On August 14, PHARMARON fell 3.22% in regular trading, trading at 29.56 HKD/share, with turnover of approximately 82.26 million HKD.On the news front, the CXO sector came under broad selling pressure following a sustained prior rally. Within the sector, WuXi AppTec declined 3.30%, GenScript Biotech fell 3.31%, and Insilico dropped 3.84%, indicating a sector-wide correction. At the company level, the controlling shareholder and concert parties had previously announced plans to reduce their combined holdings by up to 2.33%. Additionally, Norges Bank sold 2.8013 million shares on August 7 at approximately 27.23 HKD per share, totaling around 76.28 million HKD, reducing its stake to 4.49%. The confluence of institutional and major shareholder selling pressure weighed on short-term market sentiment, despite the company's upcoming board meeting on August 20 to review interim results, with previously guided first-half revenue growth of 16%-19% year-over-year and new order growth exceeding 30%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184172705","isCrawlerRequest":true}